Recap: Enanta Pharmaceuticals Q3 Earnings



Enanta Pharmaceuticals ENTA reported its Q3 earnings results on Monday, August 8, 2022 at 04:01 PM.

Here's what investors need to know about the announcement.


Enanta Pharmaceuticals missed estimated earnings by 10.07%, reporting an EPS of $-1.53 versus an estimate of $-1.39.

Revenue was down $2.15 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.2 which was followed by a 6.52% increase in the share price the next day.

Here's a look at Enanta Pharmaceuticals's past performance:


Quarter Q2 2022 Q1 2022 Q4 2021 Q3 2021
EPS Estimate -1.43 -1.09 -1.22 -1.26
EPS Actual -1.63 -1.48 -1.22 -1.19
Revenue Estimate 20.67M 27.44M 26.34M 22.14M
Revenue Actual 18.72M 27.65M 23.57M 21.62M

To track all earnings releases for Enanta Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!